AMIGOS Act: Protecting IP and Prioritizing COVID-19 Vaccine Distribution
This act aims to restrict the waiver of intellectual property rights for COVID-19 vaccines without Congressional approval. It also sets priorities for distributing excess vaccines to other countries, focusing on Latin American nations and U.S. allies, with an emphasis on monitoring their distribution. Citizens may feel the impact through U.S. foreign public health policy.
Key points
The President cannot waive intellectual property protections for COVID-19 vaccines without explicit Congressional authorization.
Excess COVID-19 vaccines will be prioritized for countries in the Western Hemisphere with the lowest immunization rates, followed by U.S. allies.
Vaccines provided to foreign countries must be marked as U.S. assistance, unless it endangers delivery personnel or administration.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.